Advances in understanding the molecular pathogenesis of CTCL

Rudolf Stadler, MD, PhD, University Medical Center Minden, Minden, Germany, discusses recent advances in our understanding of the molecular pathogenesis of cutaneous T-cell lymphoma (CTCL), highlighting the role of PD-1, and commenting on how these developments may advance therapeutic approaches. This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.